Review: Data sharing for novel coronavirus (COVID-19)

Review: Data sharing for novel coronavirus (COVID-19)

In this editorial, the authors make a compelling argument for sharing full data regarding the COVID-19 outbreak with the World Health Organization.

Sharing full data of the COVID-19 outbreak with the World Health Organization (WHO) is of utmost importance. Decision-makers must have complete and accurate information. Deficiencies in data access during previous pandemics led to agreement that expedited data and results reporting must be shared with WHO immediately. To improve timely access to data from clinical trials, observational studies, operational research, routine surveillance, disease control program monitoring, and genetic sequences, all research manuscripts will be assigned a digital object identifier (doi) and posted online in the COVID-19 Open collection of the Bulletin of the World Health Organization. Government leaders, public health officials, health researchers, and others should share information and use the data shared to make evidence-informed decisions.

|2020-04-06T09:35:46-04:00April 6th, 2020|COVID-19 Literature|Comments Off on Review: Data sharing for novel coronavirus (COVID-19)

About the Author: James Dudley

James Dudley

Get Involved with Indiana CTSI